nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—NR3C2—Betamethasone—psoriatic arthritis	0.109	0.218	CbGbCtD
Drospirenone—NR3C2—Prednisolone—psoriatic arthritis	0.107	0.215	CbGbCtD
Drospirenone—PGR—Betamethasone—psoriatic arthritis	0.0702	0.141	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—psoriatic arthritis	0.0633	0.127	CbGbCtD
Drospirenone—PGR—Dexamethasone—psoriatic arthritis	0.0409	0.082	CbGbCtD
Drospirenone—BCHE—Triamcinolone—psoriatic arthritis	0.0384	0.077	CbGbCtD
Drospirenone—PTGS2—Triamcinolone—psoriatic arthritis	0.0295	0.0592	CbGbCtD
Drospirenone—PTGS2—Betamethasone—psoriatic arthritis	0.0253	0.0508	CbGbCtD
Drospirenone—Potassium Canrenoate—Prednisone—psoriatic arthritis	0.0237	0.0501	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—psoriatic arthritis	0.0231	0.0489	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—psoriatic arthritis	0.0219	0.0464	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—psoriatic arthritis	0.0211	0.0447	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—psoriatic arthritis	0.0204	0.0431	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—psoriatic arthritis	0.0201	0.0424	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—psoriatic arthritis	0.0201	0.0424	CrCrCtD
Drospirenone—Medrysone—Prednisolone—psoriatic arthritis	0.0195	0.0413	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.0185	0.0391	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—psoriatic arthritis	0.0182	0.0384	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—psoriatic arthritis	0.0179	0.0379	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—psoriatic arthritis	0.0177	0.0373	CrCrCtD
Drospirenone—Testolactone—Betamethasone—psoriatic arthritis	0.0177	0.0373	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—psoriatic arthritis	0.0172	0.0365	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—psoriatic arthritis	0.0169	0.0357	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—psoriatic arthritis	0.0165	0.0348	CrCrCtD
Drospirenone—Testolactone—Prednisone—psoriatic arthritis	0.0164	0.0346	CrCrCtD
Drospirenone—Testolactone—Prednisolone—psoriatic arthritis	0.016	0.0338	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—psoriatic arthritis	0.0147	0.0296	CbGbCtD
Drospirenone—Progesterone—Prednisolone—psoriatic arthritis	0.0143	0.0303	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—psoriatic arthritis	0.0143	0.0302	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0139	0.0295	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.0131	0.0277	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.0129	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—psoriatic arthritis	0.0129	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.0126	0.0266	CrCrCtD
Drospirenone—Testosterone—Prednisolone—psoriatic arthritis	0.0124	0.0263	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—psoriatic arthritis	0.012	0.0253	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—psoriatic arthritis	0.0117	0.0247	CrCrCtD
Drospirenone—Infarction—Methylprednisolone—psoriatic arthritis	0.00151	0.0572	CcSEcCtD
Drospirenone—Thromboembolic event—Methotrexate—psoriatic arthritis	0.00103	0.039	CcSEcCtD
Drospirenone—Embolism venous—Prednisolone—psoriatic arthritis	0.000905	0.0343	CcSEcCtD
Drospirenone—Embolism venous—Triamcinolone—psoriatic arthritis	0.000832	0.0315	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—psoriatic arthritis	0.00083	0.0315	CcSEcCtD
Drospirenone—Embolism venous—Dexamethasone—psoriatic arthritis	0.000755	0.0286	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—psoriatic arthritis	0.000755	0.0286	CcSEcCtD
Drospirenone—Embolism—Prednisolone—psoriatic arthritis	0.000711	0.027	CcSEcCtD
Drospirenone—Embolism venous—Prednisone—psoriatic arthritis	0.000658	0.0249	CcSEcCtD
Drospirenone—Embolism—Triamcinolone—psoriatic arthritis	0.000654	0.0248	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—psoriatic arthritis	0.000653	0.0247	CcSEcCtD
Drospirenone—Loss of libido—Methotrexate—psoriatic arthritis	0.000601	0.0228	CcSEcCtD
Drospirenone—Embolism—Dexamethasone—psoriatic arthritis	0.000594	0.0225	CcSEcCtD
Drospirenone—Embolism—Betamethasone—psoriatic arthritis	0.000594	0.0225	CcSEcCtD
Drospirenone—Embolism—Prednisone—psoriatic arthritis	0.000517	0.0196	CcSEcCtD
Drospirenone—Embolism—Methotrexate—psoriatic arthritis	0.000432	0.0164	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.000379	0.159	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.000373	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.000373	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000365	0.153	CbGdCrCtD
Drospirenone—Affect lability—Prednisolone—psoriatic arthritis	0.000326	0.0124	CcSEcCtD
Drospirenone—Mood swings—Prednisolone—psoriatic arthritis	0.000314	0.0119	CcSEcCtD
Drospirenone—Nausea—Auranofin—psoriatic arthritis	0.000304	0.0115	CcSEcCtD
Drospirenone—Affect lability—Triamcinolone—psoriatic arthritis	0.0003	0.0114	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—psoriatic arthritis	0.000299	0.0113	CcSEcCtD
Drospirenone—Mood swings—Triamcinolone—psoriatic arthritis	0.000289	0.0109	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—psoriatic arthritis	0.000288	0.0109	CcSEcCtD
Drospirenone—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000275	0.0104	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—psoriatic arthritis	0.000272	0.0103	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—psoriatic arthritis	0.000272	0.0103	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—psoriatic arthritis	0.000272	0.0103	CcSEcCtD
Drospirenone—Migraine—Betamethasone—psoriatic arthritis	0.000272	0.0103	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—psoriatic arthritis	0.000262	0.00993	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—psoriatic arthritis	0.000262	0.00993	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000252	0.00955	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00025	0.00949	CcSEcCtD
Drospirenone—Affect lability—Prednisone—psoriatic arthritis	0.000237	0.00899	CcSEcCtD
Drospirenone—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000232	0.00878	CcSEcCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000231	0.00876	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—psoriatic arthritis	0.000231	0.00874	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00023	0.00873	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00023	0.00871	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—psoriatic arthritis	0.000229	0.00869	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000229	0.0957	CbGdCrCtD
Drospirenone—Mood swings—Prednisone—psoriatic arthritis	0.000228	0.00865	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000225	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000225	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00022	0.0921	CbGdCrCtD
Drospirenone—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000212	0.00803	CcSEcCtD
Drospirenone—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000212	0.00802	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000211	0.00799	CcSEcCtD
Drospirenone—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00021	0.00798	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00021	0.00796	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00021	0.00796	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000209	0.00792	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000209	0.00792	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000205	0.00779	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—psoriatic arthritis	0.000192	0.00729	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000192	0.00729	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000191	0.00725	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—psoriatic arthritis	0.000191	0.00725	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000191	0.00724	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—psoriatic arthritis	0.000191	0.00723	CcSEcCtD
Drospirenone—Depression—Prednisone—psoriatic arthritis	0.000185	0.00702	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000184	0.00699	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000183	0.00694	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—psoriatic arthritis	0.000182	0.0069	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—psoriatic arthritis	0.000182	0.0069	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—psoriatic arthritis	0.000174	0.00658	CcSEcCtD
Drospirenone—Angiopathy—Betamethasone—psoriatic arthritis	0.000174	0.00658	CcSEcCtD
Drospirenone—Haemoglobin—Prednisone—psoriatic arthritis	0.000168	0.00635	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—psoriatic arthritis	0.000167	0.00632	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000155	0.00587	CcSEcCtD
Drospirenone—Depression—Methotrexate—psoriatic arthritis	0.000155	0.00586	CcSEcCtD
Drospirenone—Angiopathy—Prednisone—psoriatic arthritis	0.000151	0.00573	CcSEcCtD
Drospirenone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000147	0.00556	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—psoriatic arthritis	0.000146	0.00553	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000145	0.0055	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—psoriatic arthritis	0.00014	0.00531	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—psoriatic arthritis	0.000139	0.00528	CcSEcCtD
Drospirenone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000133	0.00505	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000133	0.00505	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000132	0.00499	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—psoriatic arthritis	0.000126	0.00479	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000123	0.00465	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—psoriatic arthritis	0.000122	0.00462	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000117	0.00445	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000117	0.00445	CcSEcCtD
Drospirenone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000116	0.0044	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—psoriatic arthritis	0.000115	0.00436	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000103	0.00389	CcSEcCtD
Drospirenone—Nervous system disorder—Methotrexate—psoriatic arthritis	9.7e-05	0.00368	CcSEcCtD
Drospirenone—Nausea—Prednisolone—psoriatic arthritis	9.68e-05	0.00367	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—psoriatic arthritis	9.61e-05	0.00364	CcSEcCtD
Drospirenone—Nausea—Triamcinolone—psoriatic arthritis	8.9e-05	0.00337	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—psoriatic arthritis	8.88e-05	0.00337	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	8.54e-05	0.00324	CcSEcCtD
Drospirenone—Nausea—Betamethasone—psoriatic arthritis	8.08e-05	0.00306	CcSEcCtD
Drospirenone—Nausea—Dexamethasone—psoriatic arthritis	8.08e-05	0.00306	CcSEcCtD
Drospirenone—Nausea—Prednisone—psoriatic arthritis	7.03e-05	0.00267	CcSEcCtD
Drospirenone—Nausea—Methotrexate—psoriatic arthritis	5.88e-05	0.00223	CcSEcCtD
